Published in Thromb Haemost on August 04, 1987
Characterization of von Willebrand factor in primary pulmonary hypertension. Heart Vessels (1999) 0.78
Haemostatic Profile in Patients of Myeloproliferative Neoplasms-A Tertiary Care Centre Experience. J Clin Diagn Res (2016) 0.75
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med (2001) 8.95
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet (2001) 5.72
Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol (1985) 3.14
Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest (2000) 2.92
Decreased susceptibility of penicillin-resistant pneumococci to twenty-four beta-lactam antibiotics. J Antimicrob Chemother (1992) 2.86
A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD). J Thromb Haemost (2006) 2.56
[Checking oral anticoagulation in capillary blood]. Sangre (Barc) (1994) 2.56
Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression. Am J Respir Cell Mol Biol (2001) 2.49
The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost (2005) 2.45
Endoscopic ultrasound-guided fine-needle aspiration and trucut biopsy in the diagnosis of gastric stromal tumors: a randomized crossover study. Endoscopy (2010) 2.40
Heterogeneity and clonality among isolates of Mycobacterium kansasii: implications for epidemiological and pathogenicity studies. J Clin Microbiol (1997) 2.24
Evaluation of the BACTEC MGIT 960 and the MB/BacT systems for recovery of mycobacteria from clinical specimens and for species identification by DNA AccuProbe. J Clin Microbiol (2000) 2.23
TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol (2000) 2.17
A transcriptional insulator at the imprinted H19/Igf2 locus. Genes Dev (2000) 1.88
Alveolar epithelial cell death adjacent to underlying myofibroblasts in advanced fibrotic human lung. Am J Physiol (1998) 1.81
Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD). J Thromb Haemost (2008) 1.81
Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol (2013) 1.79
Human milk: a source of more life than we imagine. Benef Microbes (2013) 1.58
Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma. Am J Pathol (1998) 1.55
Presence of nitric oxide synthase activity in roots and nodules of Lupinus albus. FEBS Lett (1996) 1.49
Surfactant protein gene A, B, and D marker alleles in chronic obstructive pulmonary disease of a Mexican population. Eur Respir J (2001) 1.46
Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII. Am J Hematol (1992) 1.43
[Exercise and distribution myocardial gammagraphy with thallium-201 in patients with severe aortic valve disease and angiographically healthy coronary vessels]. Rev Esp Cardiol (1986) 1.40
[Telematics and neurology]. Rev Neurol (1996) 1.40
[Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases]. Sangre (Barc) (1993) 1.39
Problems encountered in high-level research in developing countries. Chest (1998) 1.39
[The polymerase chain reaction as a marker of cytomegalovirus infection in heart transplant recipients]. Med Clin (Barc) (1999) 1.38
[Cerebral blood flow study using SPECT in patients with memory disorders]. Rev Neurol (1997) 1.38
[Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid]. Med Clin (Barc) (1996) 1.38
Antimicrobial potential of four Lactobacillus strains isolated from breast milk. J Appl Microbiol (2006) 1.38
The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy (2009) 1.34
Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients. Blood (1997) 1.33
Uterine lipoleiomyomas: US and CT findings. Abdom Imaging (2000) 1.29
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. Antimicrob Agents Chemother (2007) 1.28
Antibiotic resistance of Streptococcus pneumoniae in childhood carriers. J Antimicrob Chemother (1987) 1.26
Differential regional and cellular distribution of dopamine D2-like receptors: an immunocytochemical study of subtype-specific antibodies in rat and human brain. J Comp Neurol (1998) 1.26
Dopamine D5 receptors of rat and human brain. Neuroscience (2000) 1.25
Surfactant protein genetic marker alleles identify a subgroup of tuberculosis in a Mexican population. J Infect Dis (2000) 1.24
Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost (1994) 1.23
Effect of delayed processing of blood samples on performance of cytomegalovirus antigenemia assay. J Clin Microbiol (1994) 1.22
Genetic variants associated with severe pneumonia in A/H1N1 influenza infection. Eur Respir J (2011) 1.17
Two Lactobacillus strains, isolated from breast milk, differently modulate the immune response. J Appl Microbiol (2007) 1.17
Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis. Antimicrob Agents Chemother (1986) 1.16
Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1. J Biol Chem (2000) 1.16
Human lung myofibroblast-derived inducers of alveolar epithelial apoptosis identified as angiotensin peptides. Am J Physiol (1999) 1.16
Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost (2006) 1.14
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma. Ann Oncol (2013) 1.13
Expression of 14 von Willebrand factor mutations identified in patients with type 1 von Willebrand disease from the MCMDM-1VWD study. J Thromb Haemost (2009) 1.13
Characterization of a highly polymorphic dinucleotide repeat 150 KB proximal to the fragile X site. Am J Med Genet (1992) 1.12
Pericardial effusion in the course of myocardial infarction: incidence, natural history, and clinical relevance. Circulation (1986) 1.12
Ischemic stroke in young adults. I. Analysis of the etiological subgroups. Acta Neurol Scand (1989) 1.11
Sclerosteosis in a Spanish male: first report in a person of Mediterranean origin. J Med Genet (1994) 1.11
Saethre-Chotzen syndrome with familial translocation at chromosome 7p22. Am J Med Genet (1993) 1.09
Fibroblasts isolated after fibrotic lung injury induce apoptosis of alveolar epithelial cells in vitro. Am J Physiol (1995) 1.08
Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis. Am J Respir Crit Care Med (1999) 1.07
Identification and characterisation of human xCT that co-expresses, with 4F2 heavy chain, the amino acid transport activity system xc-. Pflugers Arch (2001) 1.04
Comparison of techniques and evaluation of three commercial monoclonal antibodies for laboratory diagnosis of varicella-zoster virus in mucocutaneous specimens. J Clin Microbiol (1994) 1.03
Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats. Gut (2006) 1.02
Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals. Blood (1987) 1.02
Oral administration of Lactobacillus strains isolated from breast milk as an alternative for the treatment of infectious mastitis during lactation. Appl Environ Microbiol (2008) 1.01
Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study. Ann Oncol (2009) 0.96
Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteen beta-lactam antibiotics. J Antimicrob Chemother (1984) 0.96
In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer. Antimicrob Agents Chemother (2001) 0.95
Rapid detection of cows' milk in sheeps' and goats' milk by a species-specific polymerase chain reaction technique. J Dairy Sci (2004) 0.94
Novel targeted therapies in the treatment of gastric and esophageal cancer. Ann Oncol (2005) 0.94
The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitors. Blood (1986) 0.94
Comparative evaluation of novel African swine fever virus (ASF) antibody detection techniques derived from specific ASF viral genotypes with the OIE internationally prescribed serological tests. Vet Microbiol (2012) 0.94
Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect (2008) 0.93
Seasonality of cryptosporidiosis in children. Eur J Clin Microbiol Infect Dis (1996) 0.93
Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1VWD). J Thromb Haemost (2007) 0.93
Microtubule-associated protein tau facilitates the targeted killing of proliferating cancer cells in vitro and in a xenograft mouse tumour model in vivo. Br J Cancer (2013) 0.92
Myelodysplastic syndrome with erythroid hypoplasia/aplasia: a case report and review of the literature. Am J Hematol (1998) 0.92
Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis. Am J Respir Crit Care Med (2001) 0.91
Lung cancer and mutations at the polymorphic NAT2 gene locus. Pharmacogenetics (1995) 0.91
Rupture of abdominal hydatid cysts. Br J Surg (1988) 0.91
Tobacco smoke-induced lung emphysema in guinea pigs is associated with increased interstitial collagenase. Am J Physiol (1996) 0.90
Association of quantitative cytomegalovirus antigenemia with symptomatic infection in solid organ transplant patients. Diagn Microbiol Infect Dis (1996) 0.90
Comparison of several fixation methods for cytomegalovirus antigenemia assay. J Clin Microbiol (1995) 0.90
The presence of collagenase in collagen preparations. Biochim Biophys Acta (1975) 0.90
Upregulation of acidic fibroblast growth factor during development of experimental lung fibrosis. Am J Physiol (1997) 0.89
In vitro activity of azithromycin and tetracycline against 358 clinical isolates of Brucella melitensis. Eur J Clin Microbiol Infect Dis (1992) 0.88
Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. A retrospective study of 229 spontaneous bacterial peritonitis episodes. J Hepatol (1997) 0.88
In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods. J Antimicrob Chemother (2001) 0.88
Surfactant components modulate fibroblast apoptosis and type I collagen and collagenase-1 expression. Am J Physiol Lung Cell Mol Physiol (2000) 0.88
Gangrenous cholecystitis and acute cholangitis associated with anaerobic bacteria in bile. Eur J Clin Microbiol (1986) 0.87
Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts. Int Arch Allergy Immunol (2005) 0.87
Acidic fibroblast growth factor induces an antifibrogenic phenotype in human lung fibroblasts. Am J Respir Cell Mol Biol (1999) 0.87
Safety of immunotherapy with therapeutic vaccines containing depigmented and polymerized allergen extracts. Clin Exp Allergy (2007) 0.87
Development of a combined PCR-culture technique for the rapid detection of Arcobacter spp. in chicken meat. Lett Appl Microbiol (2000) 0.86
Heterogeneity of T cell lymphoblastic leukaemias. J Clin Pathol (1991) 0.86
von Willebrand disease type IIC with different abnormalities of von Willebrand factor in the same sibship. Am J Hematol (1986) 0.86
Monoclonal antibodies in the treatment of advanced colorectal cancer. Eur J Surg Oncol (2007) 0.86
Water activity and temperature effects on mycotoxin production by Alternaria alternata on a synthetic tomato medium. Int J Food Microbiol (2010) 0.86
Polymorphisms of surfactant protein gene A, B, D, and of SP-B-linked microsatellite markers in COPD of a Mexican population. Chest (2000) 0.86
Pregnancy outcome in hematologic malignancies. Cancer (1991) 0.85
Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration. Clin Exp Immunol (1985) 0.85
Epithelioid hemangiomas of the maxillofacial area. A report of three cases and a review of the literature. Int J Oral Maxillofac Surg (1997) 0.85